BIODESIX INC (BDSX)
$26.77-$1.65 (-5.79%) Today
Kieran O'Kane - Officer
Robin Harper Cowie - OfficerBiodesix Inc is a diagnostic solutions company with a focus on lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources: providing diagnostic testing services associated with blood-based lung and COVID tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties, as well as the development and commercialization of companion diagnostics.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 3 | 42,600 | $1.03M |
| Option exercise | 2 | 2,722 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
60 Form 4 filings on record, the earliest from Nov 6, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jack W. Schuler - 10% Owner | Open-market purchase | Common Stock | 15,000 | $24.47 | $367K | |
| Jack W. Schuler - 10% Owner | Open-market purchase | Common Stock | 13,900 | $24.25 | $337K | |
| Jack W. Schuler - 10% Owner | Open-market purchase | Common Stock | 13,700 | $24.01 | $329K | |
| John Patience | Option exercise | Common Stock | 1,361 | - | - | |
| John Patience | Option exercise | Restricted Stock Units | 1,361 | $0.00 | - | |
| John Patience | Option exercise | Common Stock | 1,361 | - | - | |
| John Patience | Option exercise | Restricted Stock Units | 1,361 | $0.00 | - | |
| Gary Anthony Pestano - Officer | Option exercise | Common Stock | 1,528 | - | - | |
| Gary Anthony Pestano - Officer | Open-market sale | Common Stock | 556 | $12.78 | $7K | |
| Gary Anthony Pestano - Officer | Option exercise | Restricted Stock Units | 1,528 | $0.00 | - | |
| Kieran O'Kane - Officer | Option exercise | Common Stock | 1,469 | - | - | |
| Kieran O'Kane - Officer | Open-market sale | Common Stock | 535 | $12.78 | $7K | |
| Kieran O'Kane - Officer | Option exercise | Restricted Stock Units | 1,469 | $0.00 | - | |
| Robin Harper Cowie - Officer | Option exercise | Common Stock | 1,469 | - | - | |
| Robin Harper Cowie - Officer | Open-market sale | Common Stock | 535 | $12.78 | $7K | |
| Robin Harper Cowie - Officer | Option exercise | Restricted Stock Units | 1,469 | $0.00 | - | |
| Chris Vazquez - Officer | Option exercise | Common Stock | 563 | - | - | |
| Chris Vazquez - Officer | Open-market sale | Common Stock | 211 | $12.78 | $3K | |
| Chris Vazquez - Officer | Option exercise | Restricted Stock Units | 563 | $0.00 | - | |
| Scott Hutton - Officer | Open-market sale | Common Stock | 1,490 | $12.78 | $19K | |
| Scott Hutton - Officer | Option exercise | Common Stock | 4,844 | - | - | |
| Scott Hutton - Officer | Option exercise | Restricted Stock Units | 4,844 | $0.00 | - | |
| Kieran O'Kane - Officer | Option exercise | Common Stock | 1,600 | - | - | |
| Kieran O'Kane - Officer | Open-market sale | Common Stock | 584 | $10.08 | $6K | |
| Kieran O'Kane - Officer | Option exercise | Restricted Stock Units | 73 | $0.00 | - | |
| Kieran O'Kane - Officer | Option exercise | Restricted Stock Units | 1,527 | $0.00 | - | |
| Chris Vazquez - Officer | Option exercise | Common Stock | 263 | - | - | |
| Chris Vazquez - Officer | Open-market sale | Common Stock | 101 | $10.08 | $1K | |
| Chris Vazquez - Officer | Option exercise | Restricted Stock Units | 28 | $0.00 | - | |
| Chris Vazquez - Officer | Option exercise | Restricted Stock Units | 235 | $0.00 | - | |
| Scott Hutton - Officer | Option exercise | Common Stock | 9,998 | - | - | |
| Scott Hutton - Officer | Open-market sale | Common Stock | 3,559 | $10.08 | $36K | |
| Scott Hutton - Officer | Option exercise | Restricted Stock Units | 610 | $0.00 | - | |
| Scott Hutton - Officer | Option exercise | Restricted Stock Units | 9,388 | $0.00 | - | |
| Robin Harper Cowie - Officer | Option exercise | Common Stock | 2,584 | - | - | |
| Robin Harper Cowie - Officer | Open-market sale | Common Stock | 941 | $10.08 | $9K | |
| Robin Harper Cowie - Officer | Option exercise | Restricted Stock Units | 157 | $0.00 | - | |
| Robin Harper Cowie - Officer | Option exercise | Restricted Stock Units | 2,427 | $0.00 | - | |
| Gary Anthony Pestano - Officer | Option exercise | Common Stock | 1,481 | - | - | |
| Gary Anthony Pestano - Officer | Open-market sale | Common Stock | 540 | $10.08 | $5K | |
| Gary Anthony Pestano - Officer | Option exercise | Restricted Stock Units | 68 | $0.00 | - | |
| Gary Anthony Pestano - Officer | Option exercise | Restricted Stock Units | 1,413 | $0.00 | - | |
| Jack W. Schuler | Open-market purchase | Common Stock | 80,000 | $11.81 | $945K | |
| Jack W. Schuler | Open-market purchase | Common Stock | 20,000 | $11.80 | $236K | |
| Jack W. Schuler | Open-market purchase | Common Stock | 82,465 | $10.96 | $904K | |
| Chris Vazquez - Officer | Option exercise | Common Stock | 219 | - | - | |
| Chris Vazquez - Officer | Open-market sale | Common Stock | 83 | $8.15 | $676 | |
| Chris Vazquez - Officer | Option exercise | Restricted Stock Units | 219 | $0.00 | - | |
| Gary Anthony Pestano - Officer | Option exercise | Common Stock | 805 | - | - | |
| Gary Anthony Pestano - Officer | Open-market sale | Common Stock | 298 | $8.15 | $2K | |
| Gary Anthony Pestano - Officer | Option exercise | Restricted Stock Units | 805 | $0.00 | - | |
| Kieran O'Kane - Officer | Option exercise | Common Stock | 805 | - | - | |
| Kieran O'Kane - Officer | Open-market sale | Common Stock | 298 | $8.15 | $2K | |
| Kieran O'Kane - Officer | Option exercise | Restricted Stock Units | 805 | $0.00 | - | |
| Scott Hutton - Officer | Option exercise | Common Stock | 2,633 | - | - | |
| Scott Hutton - Officer | Open-market sale | Common Stock | 970 | $8.15 | $8K | |
| Scott Hutton - Officer | Option exercise | Restricted Stock Units | 2,633 | $0.00 | - | |
| Robin Harper Cowie - Officer | Option exercise | Common Stock | 805 | - | - | |
| Robin Harper Cowie - Officer | Open-market sale | Common Stock | 298 | $8.15 | $2K | |
| Robin Harper Cowie - Officer | Option exercise | Restricted Stock Units | 805 | $0.00 | - | |
| Jean M. Franchi | Grant or award | Restricted Stock Units | 8,164 | $0.00 | - | |
| Jean M. Franchi | Grant or award | Stock Options (Right to Buy) | 6,354 | $0.00 | - | |
| Matthew Strobeck | Grant or award | Restricted Stock Units | 6,804 | $0.00 | - | |
| Matthew Strobeck | Grant or award | Stock Options (Right to Buy) | 6,354 | $0.00 | - | |
| John Patience | Option exercise | Common Stock | 1,143 | - | - | |
| John Patience | Grant or award | Restricted Stock Units | 5,443 | $0.00 | - | |
| John Patience | Grant or award | Stock Options (Right to Buy) | 6,354 | $0.00 | - | |
| John Patience | Option exercise | Restricted Stock Units | 1,143 | $0.00 | - | |
| Hany Massarany | Grant or award | Restricted Stock Units | 7,484 | $0.00 | - | |
| Hany Massarany | Grant or award | Stock Options (Right to Buy) | 6,354 | $0.00 | - | |
| Lawrence T. Kennedy Jr. | Grant or award | Restricted Stock Units | 5,443 | $0.00 | - | |
| Lawrence T. Kennedy Jr. | Grant or award | Stock Options (Right to Buy) | 6,354 | $0.00 | - | |
| Jon Faiz Kayyem | Grant or award | Restricted Stock Units | 5,443 | $0.00 | - | |
| Jon Faiz Kayyem | Grant or award | Stock Options (Right to Buy) | 6,354 | $0.00 | - | |
| Gary Anthony Pestano - Officer | Grant or award | Stock Options (Right to Buy) | 26,000 | $0.00 | - | |
| Kieran O'Kane - Officer | Grant or award | Stock Options (Right to Buy) | 27,000 | $0.00 | - | |
| Scott Hutton - Officer | Grant or award | Stock Options (Right to Buy) | 97,000 | $0.00 | - |
BIODESIX INC (BDSX) had 3 insider filings in the last 90 days, with the most recent on 2026-08-13. The full record for BDSX runs to 60 Form 4 filings, the earliest from 2024-11-06. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
3 insider purchases of BDSX were filed in the last 90 days, totaling $1.03M.
No insider sales of BDSX were filed in the last 90 days. 30 sales are on record for this company.
This page tracks BDSX Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BDSX to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
